Drug Type Small molecule drug |
Synonyms Neosaldina |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC36H56N8NaO14S |
InChIKeyRNWWIQRQNMHIFA-AXNKDMQCSA-N |
CAS Registry1801585-49-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ulcer | Phase 2 | Canada | 31 Jan 2004 | |
| Varicose Ulcer | Phase 2 | Canada | 31 Jan 2004 | |
| Wounds and Injuries | Phase 2 | Canada | 31 Jan 2004 | |
| Brain Injuries | Phase 1 | United States | - | |
| Cognitive Dysfunction | Phase 1 | United States | - | |
| Dementia, Vascular | Phase 1 | United States | - |





